192 related articles for article (PubMed ID: 34996756)
1. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.
INSPIRATION-S Investigators
BMJ; 2022 Jan; 376():e068407. PubMed ID: 34996756
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
[TBL] [Abstract][Full Text] [Related]
3. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Bikdeli B; Talasaz AH; Rashidi F; Sharif-Kashani B; Farrokhpour M; Bakhshandeh H; Sezavar H; Dabbagh A; Beigmohammadi MT; Payandemehr P; Yadollahzadeh M; Riahi T; Khalili H; Jamalkhani S; Rezaeifar P; Abedini A; Lookzadeh S; Shahmirzaei S; Tahamtan O; Matin S; Amin A; Parhizgar SE; Jimenez D; Gupta A; Madhavan MV; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Mohebbi B; Piazza G; Kirtane AJ; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Res; 2020 Dec; 196():382-394. PubMed ID: 32992075
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Talasaz AH; Sadeghipour P; Bakhshandeh H; Sharif-Kashani B; Rashidi F; Beigmohammadi MT; Moghadam KG; Rezaian S; Dabbagh A; Sezavar SH; Farrokhpour M; Abedini A; Aliannejad R; Riahi T; Yadollahzadeh M; Lookzadeh S; Rezaeifar P; Matin S; Tahamtan O; Mohammadi K; Zoghi E; Rahmani H; Hosseini SH; Mousavian SM; Abri H; Sadeghipour P; Baghizadeh E; Rafiee F; Jamalkhani S; Amin A; Mohebbi B; Parhizgar SE; Soleimanzadeh M; Aghakouchakzadeh M; Eslami V; Payandemehr P; Khalili H; Talakoob H; Tojari T; Shafaghi S; Tabrizi S; Kakavand H; Kashefizadeh A; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Ansarin K; Maleki M; Sadeghian S; Barco S; Siegerink B; Spatz ES; Piazza G; Kirtane AJ; Tassell BWV; Lip GYH; Klok FA; Goldhaber SZ; Stone GW; Krumholz HM; Bikdeli B
Thromb Haemost; 2023 Jul; 123(7):723-733. PubMed ID: 36944357
[TBL] [Abstract][Full Text] [Related]
5. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Bikdeli B; Talasaz AH; Rashidi F; Bakhshandeh H; Rafiee F; Rezaeifar P; Baghizadeh E; Matin S; Jamalkhani S; Tahamtan O; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Khalili H; Yadollahzadeh M; Riahi T; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Amin A; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Dobesh PP; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Haemost; 2022 Jan; 122(1):131-141. PubMed ID: 33865239
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Sholzberg M; Tang GH; Rahhal H; AlHamzah M; Kreuziger LB; Áinle FN; Alomran F; Alayed K; Alsheef M; AlSumait F; Pompilio CE; Sperlich C; Tangri S; Tang T; Jaksa P; Suryanarayan D; Almarshoodi M; Castellucci LA; James PD; Lillicrap D; Carrier M; Beckett A; Colovos C; Jayakar J; Arsenault MP; Wu C; Doyon K; Andreou ER; Dounaevskaia V; Tseng EK; Lim G; Fralick M; Middeldorp S; Lee AYY; Zuo F; da Costa BR; Thorpe KE; Negri EM; Cushman M; Jüni P;
BMJ; 2021 Oct; 375():n2400. PubMed ID: 34649864
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial.
Ely EW; Ramanan AV; Kartman CE; de Bono S; Liao R; Piruzeli MLB; Goldman JD; Saraiva JFK; Chakladar S; Marconi VC;
Lancet Respir Med; 2022 Apr; 10(4):327-336. PubMed ID: 35123660
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Bohula EA; Berg DD; Lopes MS; Connors JM; Babar I; Barnett CF; Chaudhry SP; Chopra A; Ginete W; Ieong MH; Katz JN; Kim EY; Kuder JF; Mazza E; McLean D; Mosier JM; Moskowitz A; Murphy SA; O'Donoghue ML; Park JG; Prasad R; Ruff CT; Shahrour MN; Sinha SS; Wiviott SD; Van Diepen S; Zainea M; Baird-Zars V; Sabatine MS; Morrow DA;
Circulation; 2022 Nov; 146(18):1344-1356. PubMed ID: 36036760
[TBL] [Abstract][Full Text] [Related]
10. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Wang TY; Wahed AS; Morris A; Kreuziger LB; Quigley JG; Lamas GA; Weissman AJ; Lopez-Sendon J; Knudson MM; Siegal DM; Kasthuri RS; Alexander AJ; Wahid L; Atassi B; Miller PJ; Lawson JW; Patel B; Krishnan JA; Shapiro NL; Martin DE; Kindzelski AL; Leifer ES; Joo J; Lyu L; Pennella A; Everett BM; Geraci MW; Anstrom KJ; Ortel TL;
Ann Intern Med; 2023 Apr; 176(4):515-523. PubMed ID: 36940444
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.
Kitas GD; Nightingale P; Armitage J; Sattar N; Belch JJF; Symmons DPM;
Arthritis Rheumatol; 2019 Sep; 71(9):1437-1449. PubMed ID: 30983166
[TBL] [Abstract][Full Text] [Related]
12. Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.
Rauch-Kröhnert U; Puccini M; Placzek M; Beyer-Westendorf J; Jakobs K; Friebel J; Hein S; Seidel M; Pieske B; Massberg S; Witzenrath M; Zeiher A; Friede T; Anker SD; Landmesser U
Clin Res Cardiol; 2023 Nov; 112(11):1620-1638. PubMed ID: 37407731
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
[TBL] [Abstract][Full Text] [Related]
14. Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial.
Perepu US; Chambers I; Wahab A; Ten Eyck P; Wu C; Dayal S; Sutamtewagul G; Bailey SR; Rosenstein LJ; Lentz SR
J Thromb Haemost; 2021 Sep; 19(9):2225-2234. PubMed ID: 34236768
[TBL] [Abstract][Full Text] [Related]
15. Add-On Prostaglandin E
Buchtele N; Schörgenhofer C; Schwameis M; Jilma B; Schellongowski P; Herkner H; Riss K; Schmid M; Hermann A; Robak O; Nagler B; Traby L; Bojic A; Staudinger T
Am J Respir Crit Care Med; 2022 Jul; 206(2):170-177. PubMed ID: 35426776
[No Abstract] [Full Text] [Related]
16. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.
Lavinio A; Ercole A; Battaglini D; Magnoni S; Badenes R; Taccone FS; Helbok R; Thomas W; Pelosi P; Robba C;
Crit Care; 2021 Apr; 25(1):155. PubMed ID: 33888132
[TBL] [Abstract][Full Text] [Related]
18. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Self WH; Semler MW; Leither LM; Casey JD; Angus DC; Brower RG; Chang SY; Collins SP; Eppensteiner JC; Filbin MR; Files DC; Gibbs KW; Ginde AA; Gong MN; Harrell FE; Hayden DL; Hough CL; Johnson NJ; Khan A; Lindsell CJ; Matthay MA; Moss M; Park PK; Rice TW; Robinson BRH; Schoenfeld DA; Shapiro NI; Steingrub JS; Ulysse CA; Weissman A; Yealy DM; Thompson BT; Brown SM; ; Steingrub J; Smithline H; Tiru B; Tidswell M; Kozikowski L; Thornton-Thompson S; De Souza L; Hou P; Baron R; Massaro A; Aisiku I; Fredenburgh L; Seethala R; Johnsky L; Riker R; Seder D; May T; Baumann M; Eldridge A; Lord C; Shapiro N; Talmor D; O’Mara T; Kirk C; Harrison K; Kurt L; Schermerhorn M; Banner-Goodspeed V; Boyle K; Dubosh N; Filbin M; Hibbert K; Parry B; Lavin-Parsons K; Pulido N; Lilley B; Lodenstein C; Margolin J; Brait K; Jones A; Galbraith J; Peacock R; Nandi U; Wachs T; Matthay M; Liu K; Kangelaris K; Wang R; Calfee C; Yee K; Hendey G; Chang S; Lim G; Qadir N; Tam A; Beutler R; Levitt J; Wilson J; Rogers A; Vojnik R; Roque J; Albertson T; Chenoweth J; Adams J; Pearson S; Juarez M; Almasri E; Fayed M; Hughes A; Hillard S; Huebinger R; Wang H; Vidales E; Patel B; Ginde A; Moss M; Baduashvili A; McKeehan J; Finck L; Higgins C; Howell M; Douglas I; Haukoos J; Hiller T; Lyle C; Cupelo A; Caruso E; Camacho C; Gravitz S; Finigan J; Griesmer C; Park P; Hyzy R; Nelson K; McDonough K; Olbrich N; Williams M; Kapoor R; Nash J; Willig M; Ford H; Gardner-Gray J; Ramesh M; Moses M; Ng Gong M; Aboodi M; Asghar A; Amosu O; Torres M; Kaur S; Chen JT; Hope A; Lopez B; Rosales K; Young You J; Mosier J; Hypes C; Natt B; Borg B; Salvagio Campbell E; Hite RD; Hudock K; Cresie A; Alhasan F; Gomez-Arroyo J; Duggal A; Mehkri O; Hastings A; Sahoo D; Abi Fadel F; Gole S; Shaner V; Wimer A; Meli Y; King A; Terndrup T; Exline M; Pannu S; Robart E; Karow S; Hough C; Robinson B; Johnson N; Henning D; Campo M; Gundel S; Seghal S; Katsandres S; Dean S; Khan A; Krol O; Jouzestani M; Huynh P; Weissman A; Yealy D; Scholl D; Adams P; McVerry B; Huang D; Angus D; Schooler J; Moore S; Files C; Miller C; Gibbs K; LaRose M; Flores L; Koehler L; Morse C; Sanders J; Langford C; Nanney K; MdalaGausi M; Yeboah P; Morris P; Sturgill J; Seif S; Cassity E; Dhar S; de Wit M; Mason J; Goodwin A; Hall G; Grady A; Chamberlain A; Brown S; Bledsoe J; Leither L; Peltan I; Starr N; Fergus M; Aston V; Montgomery Q; Smith R; Merrill M; Brown K; Armbruster B; Harris E; Middleton E; Paine R; Johnson S; Barrios M; Eppensteiner J; Limkakeng A; McGowan L; Porter T; Bouffler A; Leahy JC; deBoisblanc B; Lammi M; Happel K; Lauto P; Self W; Casey J; Semler M; Collins S; Harrell F; Lindsell C; Rice T; Stubblefield W; Gray C; Johnson J; Roth M; Hays M; Torr D; Zakaria A; Schoenfeld D; Thompson T; Hayden D; Ringwood N; Oldmixon C; Ulysse C; Morse R; Muzikansky A; Fitzgerald L; Whitaker S; Lagakos A; Brower R; Reineck L; Aggarwal N; Bienstock K; Freemer M; Maclawiw M; Weinmann G; Morrison L; Gillespie M; Kryscio R; Brodie D; Zareba W; Rompalo A; Boeckh M; Parsons P; Christie J; Hall J; Horton N; Zoloth L; Dickert N; Diercks D
JAMA; 2020 Dec; 324(21):2165-2176. PubMed ID: 33165621
[TBL] [Abstract][Full Text] [Related]
19. Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Huang DQ; Ajmera V; Tomaszewski C; LaFree A; Bettencourt R; Thompson WK; Smith DM; Malhotra A; Mehta RL; Tolia V; Yin J; Insel PA; Leachman S; Jung J; Collier S; Richards L; Woods K; Amangurbanova M; Bhatt A; Zhang X; Penciu OM; Zarich S; Retta T; Harkins MS; Teixeira JP; Chinnock B; Utay NS; Lake JE; Loomba R
Adv Ther; 2023 Nov; 40(11):4805-4816. PubMed ID: 37615850
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
Al-Samkari H; Gupta S; Leaf RK; Wang W; Rosovsky RP; Brenner SK; Hayek SS; Berlin H; Kapoor R; Shaefi S; Melamed ML; Sutherland A; Radbel J; Green A; Garibaldi BT; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Goyal N; Chan L; Mathews KS; Hedayati SS; Dy R; Toth-Manikowski SM; Zhang J; Mallappallil M; Redfern RE; Bansal AD; Short SAP; Vangel MG; Admon AJ; Semler MW; Bauer KA; Hernán MA; Leaf DE;
Ann Intern Med; 2021 May; 174(5):622-632. PubMed ID: 33493012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
